NCT07047963View on ClinicalTrials.gov

Neuropsychological Evaluation in Intellectual Disability (ENDI)

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

November 1, 2026

Conditions
Down Syndrome (Trisomy 21)NeuropsychologyCognitive AgingAlzheimer DiseaseAlzheimer Disease, Early Onset
Interventions
DIAGNOSTIC_TEST

ENDI (Neuropsychological Evaluation in Intellectual Disability)

This neuropsychological battery comprises 15 subtests designed to assess language, memory, attention and executive skills. By analyzing changes in Trisomy 21 patients performance over time, the neuropsychologist can detect early signs of Alzheimer's disease.

Trial Locations (1)

54511

CHRU de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT07047963 - Neuropsychological Evaluation in Intellectual Disability (ENDI) | Biotech Hunter | Biotech Hunter